phase-three trials

CDSCO approves shelf life of COVID-19 vaccines as 12.5 crore Indians are due for second dose-

Bharat Biotech seeks nod for phase-three trials of intranasal COVID vaccine as booster dose-

admin

By PTI HYDERABAD: Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its ...